BMI View: Despite its small population, foreign pharmaceutical firms will continue to be interested in Singapore given the highly skilled workforce and the success the country had with its biomedical sector, attracting investments into the sector. In addition, the impending launch of the Association of South East Nation Economic Community in 2015 will bring opportunities to Singapore as firms can look to market their products through the whole of ASEAN using Singapore as a base. From the healthcare perspective, the government’s promise to improve healthcare provision, alongside with the rising demand for services due to the ageing population will create …
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=113346.
Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/singapore-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.
No comments:
Post a Comment